Novel Strategy to Enhance Human Mesenchymal Stromal Cell Immunosuppression: Harnessing Interferon-Gamma Presentation in Metal-Organic Frameworks Embedded on Heparin/Collagen Multilayers.

The immunomodulatory potential of human mesenchymal stromal cells (hMSCs) can be boosted when exposed to interferon-gamma (IFN-γ). While pretreating hMSCs with IFN-γ is a common practice to enhance their immunomodulatory effects, the challenge lies in maintaining a continuous IFN-γ presence within cellular environments. Therefore, in this research, we investigate the sustainable presence of IFN-γ in the cell culture medium by immobilizing it in water-stable metal-organic frameworks (MOFs) [PCN-333(Fe)]. The immobilized IFN-γ in MOFs was coated on top of multilayers composed of combinations of heparin (HEP) and collagen (COL) that were used as a bioactive surface. Multilayers were created by using a layer-by-layer assembly technique, with the final layer alternating between collagen (COL) and heparin (HEP). We evaluated the viability, differentiation, and immunomodulatory activity of hMSCs cultured on (HEP/COL) coated with immobilized IFN-γ in MOFs after 3 and 6 days of culture. Cell viability, compared to tissue culture plastic, was not affected by immobilized IFN-γ in MOFs when they were coated on (HEP/COL) multilayers. We also verified that the osteogenic and adipogenic differentiation of the hMSCs remained unchanged. The immunomodulatory activity of hMSCs was evaluated by examining the expression of indoleamine 2,3-dioxygenase (IDO) and 11 essential immunomodulatory markers. After 6 days of culture, IDO expression and the expression of 11 immunomodulatory markers were higher in (HEP/COL) coated with immobilized IFN-γ in MOFs. Overall, (HEP/COL) multilayers coated with immobilized IFN-γ in MOFs provide a sustained presentation of cytokines to potentiate the hMSC immunomodulatory activity.

[1]  Luis Pinzon-Herrera,et al.  Delivery of Immobilized IFN-γ With PCN-333 and Its Effect on Human Mesenchymal Stem Cells. , 2023, ACS biomaterials science & engineering.

[2]  Luis Pinzon-Herrera,et al.  Immunomodulatory functions of human mesenchymal stromal cells are enhanced when cultured on HEP/COL multilayers supplemented with interferon-gamma , 2021, Materials today. Bio.

[3]  Brian J. Kwee,et al.  Functional heterogeneity of IFN-γ–licensed mesenchymal stromal cell immunosuppressive capacity on biomaterials , 2021, Proceedings of the National Academy of Sciences.

[4]  S. R. Wickramasinghe,et al.  Methods for the Assembly and Characterization of Polyelectrolyte Multilayers as Microenvironments to Modulate Human Mesenchymal Stromal Cell Response. , 2020, ACS biomaterials science & engineering.

[5]  Luis Pinzon-Herrera,et al.  Real-time monitoring of human Schwann cells on heparin-collagen coatings reveals enhanced adhesion and growth factor response. , 2020, Journal of materials chemistry. B.

[6]  Nic D. Leipzig,et al.  Metabolomic and Signaling Programs Induced by Immobilized versus Soluble IFN γ in Neural Stem Cells. , 2020, Bioconjugate chemistry.

[7]  David A. Castilla-Casadiego,et al.  Heparin/Collagen Surface Coatings Modulate the Growth, Secretome and Morphology of Human Mesenchymal Stromal Cell Response to Interferon-Gamma. , 2020, Journal of biomedical materials research. Part A.

[8]  M. H. Beyzavi,et al.  Catalytic Activity, Stability, and Loading Trends of Alcohol Dehydrogenase Enzyme Encapsulated in a Metal-Organic Framework. , 2020, ACS applied materials & interfaces.

[9]  M. Pittenger,et al.  Mesenchymal stem cell perspective: cell biology to clinical progress , 2019, npj Regenerative Medicine.

[10]  Ana M Reyes-Ramos,et al.  Effects of Physical, Chemical, and Biological Stimulus on h-MSC Expansion and Their Functional Characteristics , 2019, Annals of Biomedical Engineering.

[11]  Andrés J. García,et al.  Heparin/Collagen Coatings Improve Human Mesenchymal Stromal Cell Response to Interferon Gamma. , 2019, ACS biomaterials science & engineering.

[12]  Ross A. Marklein,et al.  Morphological features of IFN-γ–stimulated mesenchymal stromal cells predict overall immunosuppressive capacity , 2017, Proceedings of the National Academy of Sciences.

[13]  A. Ishisaki,et al.  Enhancement of Anti-Inflammatory and Osteogenic Abilities of Mesenchymal Stem Cells via Cell-to-Cell Adhesion to Periodontal Ligament-Derived Fibroblasts , 2017, Stem cells international.

[14]  Joshua A. Zimmermann,et al.  Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon‐γ Within Three‐Dimensional Mesenchymal Stem Cell Constructs , 2016, Stem cells translational medicine.

[15]  N. Puig,et al.  MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry , 2016, Cell Communication and Signaling.

[16]  H. Tse,et al.  Mesenchymal stem cells and immunomodulation: current status and future prospects , 2016, Cell Death and Disease.

[17]  Jihye Park,et al.  Dual Exchange in PCN-333: A Facile Strategy to Chemically Robust Mesoporous Chromium Metal-Organic Framework with Functional Groups. , 2015, Journal of the American Chemical Society.

[18]  W. Langridge,et al.  The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity , 2015, Vaccines.

[19]  Jie Su,et al.  Stable metal-organic frameworks containing single-molecule traps for enzyme encapsulation , 2015, Nature Communications.

[20]  Wei Cao,et al.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.

[21]  C. Akdis,et al.  Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. , 2014, The Journal of allergy and clinical immunology.

[22]  J. Karp,et al.  Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.

[23]  J. Routy,et al.  Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation. , 2014, Cytotherapy.

[24]  A. Caplan,et al.  MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation , 2013, Stem cells international.

[25]  C. Scheiermann,et al.  Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. , 2013, Annual review of immunology.

[26]  K. English.  Mechanisms of mesenchymal stromal cell immunomodulation , 2013, Immunology and cell biology.

[27]  T. Arnebrant,et al.  Influence of pH on the build-up of poly-L-lysine/heparin multilayers. , 2012, Journal of colloid and interface science.

[28]  Toshio Tanaka,et al.  Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases , 2012, International journal of biological sciences.

[29]  B. Seliger,et al.  The immunomodulatory capacity of mesenchymal stem cells. , 2012, Trends in molecular medicine.

[30]  C. Dinarello.  A clinical perspective of IL‐1β as the gatekeeper of inflammation , 2011, European journal of immunology.

[31]  Kazuo Suzuki,et al.  Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO) , 2011, PloS one.

[32]  G. Andrews,et al.  Selection of an analytical method for evaluating bovine serum albumin concentrations in pharmaceutical polymeric formulations. , 2010, Journal of pharmaceutical and biomedical analysis.

[33]  M. A. Leroux,et al.  Treatment of inflammatory diseases with mesenchymal stem cells. , 2009, Inflammation & allergy drug targets.

[34]  F. Finkelman,et al.  Untangling the Complex Web of IL-4– and IL-13–Mediated Signaling Pathways , 2008, Science Signaling.

[35]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[36]  T. Malek,et al.  The biology of interleukin-2. , 2008, Annual review of immunology.

[37]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell stem cell.

[38]  K. Atkinson,et al.  Therapeutic applications of mesenchymal stromal cells. , 2007, Seminars in cell & developmental biology.

[39]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[40]  Sergio Romagnani,et al.  Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .

[41]  A. Flake,et al.  Mesenchymal stem cells: paradoxes of passaging. , 2004, Experimental hematology.

[42]  B. Aggarwal.  Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[43]  K. Marx,et al.  Quartz crystal microbalance: a useful tool for studying thin polymer films and complex biomolecular systems at the solution-surface interface. , 2003, Biomacromolecules.

[44]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[45]  U. Hadding,et al.  A new, simple, bioassay for human IFN-γ , 1994 .

[46]  Satish K. Nune,et al.  Water‐Based Assembly of Polymer–Metal Organic Framework (MOF) Functional Coatings , 2017 .

[47]  V. Tkachuk,et al.  Regulation of Immunity via Multipotent Mesenchymal Stromal Cells , 2012, Acta naturae.

[48]  G. Fu,et al.  Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent. , 2011, Journal of biomedical materials research. Part A.

[49]  H. Okamura,et al.  Interleukin-18 regulates both Th1 and Th2 responses. , 2001, Annual review of immunology.